CLINICAL ROLE -
ASTHMA WATCH
ARTHRITIS WATCH
The Mystery of Prion Diseases
Drugs for Rare Diseases Are Coming to Market
Controlled Substances Proposed Rule: Missed Opportunity?
health-systems PRODUCT news
Many Potential Sources for Drug-induced Rhabdomyolysis
The views expressed are those of the author and not those of any government agency.
generic times: product profiles
Blockbuster Patent Expirations Bring a Shift in Business Models
generic times product news
IDENTIFYING PATIENTS AT RISK FOR RECURRENT VTE
USE OF ASPIRIN AND IBUPROFEN
FIXED-DOSE HEPARIN EFFECTIVE IN VTE TREATMENT
RESOURCES AVAILABLE FOR PATIENTS WITH CLOTTING DISORDERS
TIAs: WHAT TO DO WHEN ASPIRIN IS NOT ENOUGH
E-pedigrees Need Uniformity to Work Effectively
GPhA PRESSES CONGRESS FOR CHANGES IN PATENT REFORM BILL
BIOVAIL SUES FDA OVER GENERIC WELLBUTRIN XL
FTC COMMISSIONER WARNS OF ANTIGENERIC TACTICS
MYLAN ACQUIRES INDIAN GENERIC DRUG MAKER MATRIX LABS
FIRST GENERIC CIPRO IV GET FDA GREEN LIGHT
GENERIC COMPANY HONORS AUTISM GROUP
case STUDY
GENERIC FIRMS AGREE TO OXYCONTIN SETTLEMENT
STUDY IDENTIFIES WIDESPREAD ANTIGENERIC PRACTICES
Predicting the Magnitude of Drug Interactions: The Final Frontier
An Overview of Insulin Breakthroughs
Novo Nordisk's Levemir
GlaxoSmithKline's Avandamet
ACTIVIST GROUP ATTACKS PHARMACIST COMPOUNDING?
